C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 403/00 (2006.01) A61K 31/415 (2006.01) C07D 403/04 (2006.01) C07D 403/06 (2006.01)
Patent
CA 2129679
Disclosed is a compound of formula (I) or a pharmaceutically acceptable salt or solvate thereof. Also disclosed are pharmaceutical compositions comprising a pharmaceutically acceptable carrier and an effective amount of a compound of formula (I). Further disclosed is a method of treating allergy (for example asthma), inflammation, hypertension, raised intraocular pressure (such as glaucoma)--i.e., a method of lowering intraocular pressure, sleeping disorders, states of hyper and hypo motility and acidic secretion of the gastrointestinal tract, hypo and hyerpactivity of the central nervous system (for example, agitation and depression) and other CNS disorders (such as Alzheimers, schizophrenia, and migraine) comprising administering an effective amount of a compound of formula (I) to a patient in need of such treatment.
Composé de la formule (I) ou sel ou solvate pharmaceutiquement acceptable dudit composé et compositions pharmaceutiques comportant un excipient pharmaceutiquement acceptable et une quantité efficace d'un composé de la formule (I). La présente invention décrit également une méthode destinée à traiter l'allergie (par exemple l'asthme), l'inflammation, l'hypertension, l'augmentation de la pression intraoculaire (telle que le glaucome), c'est-à-dire une méthode de réduction de la pression intraoculaire, les troubles du sommeil, les états d'hypermotilité et d'hypomotilité et la secrétion acide des voies gastro-intestinales, d'hypoactivité et d'hyperactivité du système nerveux central (par exemple l'agitation et la dépression) et les autres troubles du système nerveux central (tels que la maladie d'Alzheimer, la schizophrénie et la migraine), qui consiste à administrer une quantité efficace d'un composé de la formule (I) à un patient nécessitant un tel traitement.
Aslanian Robert
Ganguly Ashit K.
Green Michael J.
Lupo Andrew Jr.
Piwinski John J.
Ogilvy Renault Llp/s.e.n.c.r.l.,s.r.l.
Schering Corporation
LandOfFree
Imidazolyl or imidazoylalkyl substituted with a four or five... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Imidazolyl or imidazoylalkyl substituted with a four or five..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Imidazolyl or imidazoylalkyl substituted with a four or five... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1640900